We first tested whether ERLIN2 can interact with α- and/or β-tubulin, the key components that make up microtubules [26], in the human breast cancer cell line SUM225 and in a stable CHO cell line overexpressing ERLIN2. Here, ERLIN2 is linked to breast carcinoma.